Details

NameSymbolSector
AARTI DRUGS LIMITEDAARTIDRUGSPharmaceuticals
Open
493
High
494.8
Low
482.05
Close
486.65
Volume
69299
Exchange
nse
Time
14/08

Outlook

Score:  

0.5

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Aarti Drugs is  
None
Estimated Stoploss of Aarti Drugs is ₹  
494.8
Aarti Drugs has a  
Bearishℹ
 pattern. 
Formation of  
None
 candle pattern indicates the trend direction of Aarti Drugs is  
Unpredictableℹ
. 

Trend

Aarti Drugs is in  
Downtrendℹ
. 
Price of Aarti Drugs is  
Downℹ
 by  

1.35

%. 
Target
Buy @ 

470.1

Sell @ 

496.8

Volume

The trade volumes of Aarti Drugs have become  
Deficientℹ
The volume trend for Aarti Drugs is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Aarti Drugs is  

Down

 by  

84.82

% 

Valuation

The current market price of Aarti Drugs is  
Undervaluedℹ

Financials

Balance
The balance sheet of Aarti Drugs is:  

Balanced

Cashflow
Aarti Drugs has  
Insufficientℹ
 cash flow because there is  

Shortage

 of  

₹ 2cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2025)

49.8% i.e. ₹ 244cr earned in operatingℹ
33.47% i.e. ₹ 164cr spent in investingℹ
16.73% i.e. ₹ 82cr spent in financingℹ
0% in otherℹ
Aarti Drugs has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Upℹ
 by  

100

%. 

(*Mar 2024)

49.93% i.e. ₹ 358cr earned in operatingℹ
31.1% i.e. ₹ 223cr spent in investingℹ
18.97% i.e. ₹ 136cr spent in financingℹ
0% in otherℹ
Income
The income of Aarti Drugs is  

₹ 590cr

 and  

Profit

 is :  

₹ 53cr

(*Jun 2025)

Aarti Drugs Profit is down by:  

14.52

% and Income is Down by:  

12.98

% 

(*Jun 2025)

The income of Aarti Drugs is  

₹ 678cr

 and  

Profit

 is :  

₹ 62cr

(*Mar 2025)

Aarti Drugs Profit is up by:  

67.57

% and Income is Up by:  

19.37

% 

(*Mar 2025)

The income of Aarti Drugs is  

₹ 568cr

 and  

Profit

 is :  

₹ 37cr

(*Dec 2024)

Aarti Drugs Profit is up by:  

8.82

% and Income is Down by:  

5.18

% 

(*Dec 2024)

By using this site you agree to the use of cookies to deliver a better site experience.